← 返回

声门上喉鳞状细胞癌中 PD-L1 表达及相关 TIL(肿瘤浸润淋巴细胞)的预后意义

英文原题:The Prognostic Significance of PD-L1 Expression and Associated Tumor-Infiltrating Lymphocytes in Supraglottic Laryngeal Squamous Cell Carcinoma.

查看英文原题

The Prognostic Significance of PD-L1 Expression and Associated Tumor-Infiltrating Lymphocytes in Supraglottic Laryngeal Squamous Cell Carcinoma.

PubMed 2025/02/01(内容时间) APMIS Q2 · IF 2.2(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

喉鳞状细胞癌(LSCC)以TIL(肿瘤浸润淋巴细胞)(TILs)的不同特征为特点。我们旨在探讨TILs和程序性死亡配体1(PD-L1)在声门上型LSCC患者中的潜在预后作用。采用免疫组化方法评估39例原发性声门上型LSCC患者中PD-L1和TILs的表达,并与临床病理特征和无病生存期(DFS)进行相关性分析。采用Kaplan-Meier法绘制生存曲线,采用log-rank检验评估组间生存差异。PD-L1阳性(联合阳性评分:CPS 1)患者的TIL密度显著高于PD-L1阴性(CPS < 1)患者(p = 0.000)。较低的PD-L1表达与局部区域复发显著相关(Fisher精确检验,p = 0.008)。CPS 1患者的DFS显著长于CPS < 1患者(Log-rank检验,p = 0.004)。多因素Cox回归分析显示,低CPS(p = 0.003)和阳性淋巴结状态(p = 0.012)是恶性肿瘤复发的独立预测因素,具有统计学意义。PD-L1是预测根治性治疗后复发和较短生存期的有价值标志物。

展开英文摘要原文

Laryngeal squamous cell carcinoma (LSCC) is characterized by diverse profiles of tumor-infiltrating lymphocytes (TILs).

We aimed to investigate the potential prognostic role of TILs and programmed death-ligand 1 (PD-L1) in patients with supraglottic LSCC. The expression of PD-L1 and TILs was assessed using immunohistochemistry in 39 patients with primary supraglottic LSCC and correlated with clinicopathological characteristics and disease-free survival (DFS). Survival curves were measured using the Kaplan-Meier method, and differences in survival between the groups were estimated using the log-rank test. TIL density was significantly higher in PD-L1-positive (combined positive score: CPS 1) than in PD-L1-negative (CPS < 1) patients (p = 0.

000). Lower PD-L1 expression was significantly associated with a locoregional recurrence (Fisher's exact test, p = 0. 008). DFS was significantly longer in patients with CPS 1 than in those with CPS < 1 (Log-rank test, p = 0. 004). Multivariate Cox regression analysis showed that a low CPS (p = 0. 003) and positive nodal status (p = 0. 012) were statistically significant and independent predictors of malignancy recurrence. PD-L1 represents a valuable marker for predicting recurrence and shorter survival after definitive therapy.

论文信息

作者
Zvrko E、Kadic M、Vuckovic L
单位
Clinical Center of Montenegro, Podgorica, Montenegro.
期刊
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica2025 Feb
原文标识
PubMed 39957467 · DOI 10.1111/apm.70005